Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
Jauw YW, Menke-van der Houven van Oordt CW, Hoekstra OS, Hendrikse NH, Vugts DJ, Zijlstra JM, Huisman MC, van Dongen GA. Jauw YW, et al. Among authors: huisman mc. Front Pharmacol. 2016 May 24;7:131. doi: 10.3389/fphar.2016.00131. eCollection 2016. Front Pharmacol. 2016. PMID: 27252651 Free PMC article. Review.
Radiation dose of the P-glycoprotein tracer 11C-laniquidar.
Postnov A, Froklage FE, van Lingen A, Reijneveld JC, Hendrikse NH, Windhorst AD, Schuit RC, Eriksson J, Lammertsma AA, Huisman MC. Postnov A, et al. Among authors: huisman mc. J Nucl Med. 2013 Dec;54(12):2101-3. doi: 10.2967/jnumed.113.120857. Epub 2013 Oct 3. J Nucl Med. 2013. PMID: 24092938 Free article. Clinical Trial.
Multicenter harmonization of 89Zr PET/CT performance.
Makris NE, Boellaard R, Visser EP, de Jong JR, Vanderlinden B, Wierts R, van der Veen BJ, Greuter HJ, Vugts DJ, van Dongen GA, Lammertsma AA, Huisman MC. Makris NE, et al. Among authors: huisman mc. J Nucl Med. 2014 Feb;55(2):264-7. doi: 10.2967/jnumed.113.130112. Epub 2013 Dec 19. J Nucl Med. 2014. PMID: 24357686 Free article.
PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab.
Makris NE, Boellaard R, van Lingen A, Lammertsma AA, van Dongen GA, Verheul HM, Menke CW, Huisman MC. Makris NE, et al. Among authors: huisman mc. J Nucl Med. 2015 Feb;56(2):249-54. doi: 10.2967/jnumed.114.147819. Epub 2015 Jan 22. J Nucl Med. 2015. PMID: 25613538 Free article.
89Zr-cetuximab PET imaging in patients with advanced colorectal cancer.
Menke-van der Houven van Oordt CW, Gootjes EC, Huisman MC, Vugts DJ, Roth C, Luik AM, Mulder ER, Schuit RC, Boellaard R, Hoekstra OS, van Dongen GA, Verheul HM. Menke-van der Houven van Oordt CW, et al. Among authors: huisman mc. Oncotarget. 2015 Oct 6;6(30):30384-93. doi: 10.18632/oncotarget.4672. Oncotarget. 2015. PMID: 26309164 Free PMC article. Clinical Trial.
124I PET/CT to Predict the Outcome of Blind 131I Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET).
Kist JW, de Keizer B, van der Vlies M, Brouwers AH, Huysmans DA, van der Zant FM, Hermsen R, Stokkel MP, Hoekstra OS, Vogel WV; THYROPET Study Group; other members of the THYROPET Study group are John M.H. de Klerk. Kist JW, et al. J Nucl Med. 2016 May;57(5):701-7. doi: 10.2967/jnumed.115.168138. Epub 2015 Nov 25. J Nucl Med. 2016. PMID: 26609180 Free article. Clinical Trial.
88 results